Amy DiCamillo

Corporate Officer/Principal bei Melior Discovery, Inc.

Commercial Services

Consumer Services

Aktive Positionen von Amy DiCamillo

Unternehmen	Position	Beginn	Ende
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Corporate Officer/Principal	-	-
	Technik-/Wissenschafts-/F&E-Leiter	-	-

West Chester University of Pennsylvania

Graduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Graduate Degree	1

Sektoral

Commercial Services	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Commercial Services

Private Unternehmen

Commercial Services